Overview

Generic Tacrolimus in the Elderly - Prograf® vs Tacni®

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Test bioequivalence of generic tacrolimus (Tacni), using original tacrolimus (Prograf) as comparator, in elderly (>60 yr) renal transplant recipients
Phase:
Phase 4
Details
Lead Sponsor:
University of Oslo School of Pharmacy
Collaborator:
Oslo University Hospital
Treatments:
Tacrolimus